Phase-variable Heptose I glycan extensions modulate efficacy of 2C7 vaccine antibody directed against Neisseria gonorrhoeae lipooligosaccharide

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.4049/jimmunol.1600374
AuthorSearch for: ; Search for: ; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for:
Name affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Abstract
Publication date
PublisherAmerican Association of Immunologists, Inc
In
LanguageEnglish
Peer reviewedYes
NPARC number23000435
Export citationExport as RIS
Report a correctionReport a correction
Record identifierf87202e0-9f7a-4295-b3b1-c40cfbd5103a
Record created2016-07-15
Record modified2020-03-16
Date modified: